Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
Ciprofloxacin
Aspen Pharmacare Australia Pty Ltd
Medicine Registered
ASPEN CIPROFLOXACIN Injection for Intravenous Infusion – CMI Page 1 of 3 ASPEN CIPROFLOXACIN INJECTION FOR INTRAVENOUS INFUSION CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some common questions about ASPEN CIPROFLOXACIN Injection for Intravenous Infusion. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you being given ASPEN CIPROFLOXACIN Injection for Intravenous Infusion against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT BEING GIVEN THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH THE MEDICINE._ _ _ _ You may need to read it again. WHAT ASPEN CIPROFLOXACIN INJECTION FOR INTRAVENOUS INFUSION IS USED FOR ASPEN CIPROFLOXACIN Injection for Intravenous Infusion contains ciprofloxacin (as ciprofloxacin lactate) as the active ingredient. It belongs to a group of antibiotics called fluoroquinolones. _ _ This medicine is used to treat many different conditions including: lung infections infections of skin infections of bone and joints kidney and bladder infections infections in the blood inhalation of anthrax (post- exposure). It works by killing many kinds of bacteria which cause infections in the body. Ciprofloxacin will not work against infections caused by viruses such as cold and flu. ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS ABOUT WHY THIS MEDICINE HAS BEEN PRESCRIBED FOR YOU. Your doctor may have prescribed it for another reason. It is available only with a doctor’s prescription. There is no evidence t Read the complete document
ASPEN CIPROFLOXACIN Injection for Intravenous Infusion – PI Page 1 of 11 PRODUCT INFORMATION ASPEN CIPROFLOXACIN INJECTION FOR INTRAVENOUS INFUSION NAME OF THE MEDICINE Ciprofloxacin The chemical structure is shown below: DESCRIPTION Aspen Ciprofloxacin Injection for Intravenous Infusion is a synthetic carboxyquinolone derivative with broad spectrum antimicrobial activity for intravenous (IV) administration. Ciprofloxacin, a fluoroquinolone, is a 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3- quinolinecarboxylic acid. Its empirical formula is C 17 H 18 FN 3 O 3 and it has a molecular weight of 331.4 (CAS registry number 85721-33-1). Ciprofloxacin is a faint to light yellow crystalline powder. Aspen Ciprofloxacin Injection for Intravenous Infusion is available as a ciprofloxacin (as lactate) 100 mg/50 mL and a 200 mg/100 mL infusion solution. It also contains the excipients lactic acid (as a solubilising agent), glucose (55 mg/mL) and water for injections. Aspen Ciprofloxacin Injection for Intravenous Infusion is a clear, colourless to a slightly yellowish solution. PHARMACOLOGY PHARMACOKINETICS _Distribution _ Immediately following a 30 minute intravenous infusion of 200 mg ciprofloxacin, serum concentrations average 3 microgram/mL. During the first hour after completion of infusion, serum concentration decreases to approximately 30% of the peak value, but thereafter serum concentrations decline with a half life of approximately four hours. Mean concentrations observed after a 200 mg dose are given below: CIPROFLOXACIN SERUM CONCENTRATIONS (MICROGRAM/ML) AFTER A 30 MINUTE INFUSION DOSE END OF INFUSION 0.5 HR 1 HR 3 HR 6 HR 8 HR 12 HR 200 mg 3.18 1.4 1.0 0.5 0.3 0.2 0.1 Read the complete document